JP2011525103A - ディスプレイベクター並びにその方法及び用途 - Google Patents
ディスプレイベクター並びにその方法及び用途 Download PDFInfo
- Publication number
- JP2011525103A JP2011525103A JP2010541795A JP2010541795A JP2011525103A JP 2011525103 A JP2011525103 A JP 2011525103A JP 2010541795 A JP2010541795 A JP 2010541795A JP 2010541795 A JP2010541795 A JP 2010541795A JP 2011525103 A JP2011525103 A JP 2011525103A
- Authority
- JP
- Japan
- Prior art keywords
- poly
- peptide
- vector
- cell
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 title claims abstract description 169
- 238000000034 method Methods 0.000 title claims description 32
- 210000004027 cell Anatomy 0.000 claims abstract description 293
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 279
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims abstract description 99
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 58
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 58
- 239000002157 polynucleotide Substances 0.000 claims abstract description 58
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 27
- 230000027455 binding Effects 0.000 claims description 100
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 42
- 108060003951 Immunoglobulin Proteins 0.000 claims description 33
- 102000018358 immunoglobulin Human genes 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 27
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 235000018102 proteins Nutrition 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 230000009870 specific binding Effects 0.000 claims description 16
- 150000007523 nucleic acids Chemical group 0.000 claims description 15
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 11
- 210000004962 mammalian cell Anatomy 0.000 claims description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 9
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 claims description 7
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 101710186708 Agglutinin Proteins 0.000 claims description 6
- 101710146024 Horcolin Proteins 0.000 claims description 6
- 101710189395 Lectin Proteins 0.000 claims description 6
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 6
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 6
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 6
- 239000000910 agglutinin Substances 0.000 claims description 6
- 108091008874 T cell receptors Proteins 0.000 claims description 4
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 4
- 101100083069 Candida albicans (strain SC5314 / ATCC MYA-2876) PGA62 gene Proteins 0.000 claims description 3
- 101100106993 Candida albicans (strain SC5314 / ATCC MYA-2876) YWP1 gene Proteins 0.000 claims description 3
- 101150054379 FLO1 gene Proteins 0.000 claims description 3
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 claims description 3
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 claims description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 3
- 238000011160 research Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 23
- 229920001184 polypeptide Polymers 0.000 description 15
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 210000000170 cell membrane Anatomy 0.000 description 11
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 11
- 238000001890 transfection Methods 0.000 description 10
- 102000037865 fusion proteins Human genes 0.000 description 9
- 108020001507 fusion proteins Proteins 0.000 description 9
- 238000001514 detection method Methods 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 102000018697 Membrane Proteins Human genes 0.000 description 6
- 108010052285 Membrane Proteins Proteins 0.000 description 6
- 210000003850 cellular structure Anatomy 0.000 description 6
- 235000018417 cysteine Nutrition 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 238000000684 flow cytometry Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 5
- 241000288906 Primates Species 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 4
- 102000018967 Platelet-Derived Growth Factor beta Receptor Human genes 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 108091008606 PDGF receptors Proteins 0.000 description 3
- 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 108010027122 ADP-ribosyl Cyclase 1 Proteins 0.000 description 2
- 102000018667 ADP-ribosyl Cyclase 1 Human genes 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 108091054437 MHC class I family Proteins 0.000 description 2
- 108091054438 MHC class II family Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 101800000112 Acidic peptide Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101000677856 Stenotrophomonas maltophilia (strain K279a) Actin-binding protein Smlt3054 Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010091748 peptide A Proteins 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000002702 ribosome display Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2045608P | 2008-01-11 | 2008-01-11 | |
| US61/020,456 | 2008-01-11 | ||
| PCT/EP2009/050237 WO2009087230A1 (en) | 2008-01-11 | 2009-01-09 | Display vectors and methods and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011525103A true JP2011525103A (ja) | 2011-09-15 |
| JP2011525103A5 JP2011525103A5 (enExample) | 2013-02-21 |
Family
ID=40532579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541795A Pending JP2011525103A (ja) | 2008-01-11 | 2009-01-09 | ディスプレイベクター並びにその方法及び用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100317546A1 (enExample) |
| EP (1) | EP2235181A1 (enExample) |
| JP (1) | JP2011525103A (enExample) |
| AU (1) | AU2009203699A1 (enExample) |
| CA (1) | CA2711806A1 (enExample) |
| WO (1) | WO2009087230A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015522286A (ja) * | 2012-07-18 | 2015-08-06 | エヌビーイー セラピューティクス リミテッド ライアビリティ カンパニー | 特異的な結合タンパク質または機能性タンパク質の遺伝子転位を利用した同定 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100089816A (ko) | 2007-08-21 | 2010-08-12 | 모르포시스 아게 | 이황화 결합을 형성하기 위한 개선된 방법 |
| EP4349997A3 (en) | 2015-09-24 | 2024-07-10 | Daiichi Sankyo Company, Limited | Anti-garp antibody |
| PT3428194T (pt) | 2017-07-14 | 2021-11-18 | Immatics Biotechnologies Gmbh | Molécula de polipéptido com especificidade dupla melhorada |
| BR112023022765A2 (pt) | 2021-05-05 | 2024-01-02 | Immatics Biotechnologies Gmbh | Proteínas de ligação ao antígeno que ligam especificamente o prame |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420140B1 (en) * | 1996-10-11 | 2002-07-16 | Abgenix, Inc. | Production of multimeric protein by cell fusion method |
| WO2003029456A1 (en) * | 2001-10-01 | 2003-04-10 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| ATE476503T1 (de) * | 2001-10-01 | 2010-08-15 | Deutsches Krebsforsch | Verfahren zur herstellung von protein- bibliotheken und zur selektion von proteinen daraus |
| JP2009535063A (ja) * | 2006-05-04 | 2009-10-01 | アブマクシス・インコーポレイテツド | 異種間及び複数種提示系 |
| US8637435B2 (en) * | 2007-11-16 | 2014-01-28 | Merck Sharp & Dohme Corp. | Eukaryotic cell display systems |
-
2009
- 2009-01-09 US US12/812,236 patent/US20100317546A1/en not_active Abandoned
- 2009-01-09 EP EP09700624A patent/EP2235181A1/en not_active Withdrawn
- 2009-01-09 CA CA2711806A patent/CA2711806A1/en not_active Abandoned
- 2009-01-09 WO PCT/EP2009/050237 patent/WO2009087230A1/en not_active Ceased
- 2009-01-09 AU AU2009203699A patent/AU2009203699A1/en not_active Abandoned
- 2009-01-09 JP JP2010541795A patent/JP2011525103A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015522286A (ja) * | 2012-07-18 | 2015-08-06 | エヌビーイー セラピューティクス リミテッド ライアビリティ カンパニー | 特異的な結合タンパク質または機能性タンパク質の遺伝子転位を利用した同定 |
| US10174309B2 (en) | 2012-07-18 | 2019-01-08 | Nbe-Therapeutics Llc | Transposition-mediated identification of specific binding or functional proteins |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2711806A1 (en) | 2009-07-16 |
| US20100317546A1 (en) | 2010-12-16 |
| WO2009087230A1 (en) | 2009-07-16 |
| AU2009203699A1 (en) | 2009-07-16 |
| EP2235181A1 (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5111558B2 (ja) | 多重鎖真核ディスプレイベクターとその使用 | |
| CN111801446B (zh) | 一种用于分离G蛋白偶联受体(GPCRs)的功能性抗体的酵母表型筛选方法 | |
| KR20110104052A (ko) | 효모 디스플레이 시스템 | |
| CN101512337A (zh) | 跨物种与多物种展示系统 | |
| US20100317546A1 (en) | Display Vectors and Methods and Uses Thereof | |
| US20200140573A1 (en) | Nucleic acid compositions, methods and kits for rapid pairing of affinity agents | |
| JP2011193728A (ja) | ＥｐＣＡＭに結合能を有するペプチド | |
| AU2010336004B2 (en) | Protein display | |
| AU2017328633B2 (en) | Bispecific antibody display on phage surface | |
| SG11202109391PA (en) | Method for the generation of an fcrn expressing cell by targeted integration of multiple expression cassettes in a defined organization | |
| WO2010079189A1 (en) | Display vectors and methods and uses thereof | |
| CA3035132C (en) | Bispecific antibody display on phage surface | |
| JP2026516109A (ja) | 相互作用を検出する方法 | |
| CN117384936A (zh) | 一种酵母展示载体及酵母展示双特异Fab的方法 | |
| CN117384937A (zh) | 一种高效酵母展示载体及酵母展示方法 | |
| JP2009261371A (ja) | 細胞の表層にビオチンを提示した微生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111212 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111212 |
|
| A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20130507 |